Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2026)
Ginkgo Bioworks Holdings' (DNA) quarterly Intangibles came in at $44.4 million in Q2 2026, down 32.9% on a YoY basis from $66.2 million in Q2 2025, and down 9.15% quarter-over-quarter from $48.9 million in Q1 2026.
Analysis
Ginkgo Bioworks Holdings (DNA) Intangibles (2020 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Intangibles for 7 consecutive years, with $44.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Intangibles fell 32.9% year-over-year to $44.4 million; the trailing twelve-month figure through Jun 2026 stood at $44.4 million (down 32.9% YoY), and the FY2025 full-year result was $53.5 million, down 26.24% from the prior year.
- Intangibles retreated to $44.4 million in Q2 2026 per DNA's latest filing, from $48.9 million in the prior quarter.
- Across five years, Intangibles topped out at $111.0 million in Q4 2022 and bottomed at $20.8 million in Q1 2022.
- Historically, Intangibles has averaged $71.1 million across 5 years, with a median of $70.6 million in 2024.
- The sharpest annual moves came in 2023 and 2026: Intangibles surged 422.04% in 2023, then plunged 32.9% in 2026.
- Over 5 years, Intangibles stood at $111.0 million in 2022, then slipped by 25.49% to $82.7 million in 2023, then dropped by 12.37% to $72.5 million in 2024, then declined by 26.24% to $53.5 million in 2025, then dropped by 17.01% to $44.4 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $44.4 million, $48.9 million, and $53.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 4.75 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 33.11 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | 253.17 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 3.15 Bn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | 586.80 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | 44.39 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.39 Mn |
| Mar 31, 2026 | 48.86 Mn |
| Dec 31, 2025 | 53.48 Mn |
| Sep 30, 2025 | 61.52 Mn |
| Jun 30, 2025 | 66.15 Mn |
| Mar 31, 2025 | 68.76 Mn |
| Dec 31, 2024 | 72.51 Mn |
| Sep 30, 2024 | 79.57 Mn |
| Jun 30, 2024 | 90.60 Mn |
| Mar 31, 2024 | 77.41 Mn |
| Dec 31, 2023 | 82.74 Mn |
| Sep 30, 2023 | 100.17 Mn |
| Jun 30, 2023 | 105.03 Mn |
| Mar 31, 2023 | 108.74 Mn |
| Dec 31, 2022 | 111.04 Mn |
| Sep 30, 2022 | 47.94 Mn |
| Jun 30, 2022 | 39.18 Mn |
| Mar 31, 2022 | 20.83 Mn |
| Dec 31, 2021 | 21.64 Mn |
| Sep 30, 2021 | 22.57 Mn |